+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cattle & Porcine/Swine Reproductive Diseases Market - Global Forecast 2026-2032- Product Image
Cattle & Porcine/Swine Reproductive Diseases Market - Global Forecast 2026-2032- Product Image
Sale

Cattle & Porcine/Swine Reproductive Diseases Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6055575
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cattle & Porcine/Swine Reproductive Diseases Market is projected to reach USD 1.54 Billion in 2026. It is expected to continue growing at a CAGR of 11.63%, reaching USD 2.97 Billion by 2032.

Cattle and Swine Reproductive Diseases: Executive Overview

Cattle and porcine reproductive diseases affect fertility, conception, gestation, farrowing, calving, neonatal survival, and herd replacement. Their effects extend beyond individual animals to biosecurity, animal welfare, productivity, veterinary workload, and continuity of food production. Disease management therefore depends on coordinated surveillance, vaccination where appropriate, reproductive-record analysis, laboratory confirmation, prudent treatment, and disciplined movement controls.

Integrated Herd Health Is Reshaping Disease Management

The landscape is shifting from reactive treatment toward prevention based on herd-level risk assessment. Producers and veterinarians increasingly combine reproductive performance records with vaccination protocols, quarantine, semen and breeding-stock controls, hygiene, vector management, nutrition, and testing of animals or environmental samples. Greater attention to antimicrobial stewardship is also encouraging differential diagnosis and targeted therapy rather than routine medication. Climate variability, intensified production, animal movement, and uneven veterinary access continue to complicate control, making locally adapted biosecurity and cross-border coordination essential.

Artificial Intelligence Strengthens Surveillance and Decision Support

Artificial intelligence can improve detection of reproductive problems by identifying unusual patterns in conception rates, returns to estrus, abortions, stillbirths, farrowing outcomes, and neonatal losses. When linked with electronic identification, reproductive software, laboratory results, imaging, and environmental data, machine-learning tools may support earlier investigation and more precise intervention. Practical limitations remain, including inconsistent data quality, limited labeled disease records, interoperability gaps, privacy concerns, and the need for veterinary validation. AI should therefore augment-not replace-clinical examination, laboratory confirmation, and responsible professional judgment.

Regional Priorities Differ Across Production and Disease Environments

North America combines advanced herd-record systems with substantial movement between production units, emphasizing traceability, testing, vaccination, and antimicrobial stewardship. Latin America requires approaches suited to varied farm structures, tropical and subtropical conditions, and differences in veterinary access, with strong value from extension services and practical biosecurity. Europe prioritizes coordinated surveillance, animal identification, welfare, and regulatory compliance. The Middle East faces challenges associated with arid conditions, import dependence, and transboundary livestock movement. Africa benefits from strengthened diagnostic networks, mobile veterinary services, vaccination access, and smallholder-focused education. Asia-Pacific spans highly diverse production systems, so scalable surveillance, quarantine, farmer training, and laboratory capacity are central priorities.

Economic and Policy Groups Shape Different Control Capabilities

ASEAN countries benefit from regional cooperation on movement controls, laboratory sharing, and producer education while managing diverse production systems and disease pressures. BRICS members span major livestock populations and can advance research, diagnostics, vaccine development, and harmonized surveillance, although implementation capacity varies. The European Union emphasizes common animal-health rules, traceability, and coordinated reporting. G7 members generally have strong diagnostic and regulatory infrastructure but must manage intensive production, trade, and antimicrobial-resistance concerns. GCC countries place particular emphasis on import controls, quarantine, and protection of concentrated livestock operations. NATO members may benefit from resilience planning, civil-agency coordination, and preparedness for animal-health disruptions that affect food systems.

Country Contexts Require Locally Adapted Reproductive-Health Programs

Australia emphasizes extensive production, biosecurity, and movement management across large distances. Brazil combines major cattle and swine sectors with varied regional conditions, making surveillance and producer outreach important. Canada and the United States rely heavily on structured herd health, traceability, and veterinary-led reproductive monitoring. China and India require approaches that address scale, production diversity, and uneven access to diagnostics. Japan and South Korea emphasize intensive production, rapid detection, and strict farm biosecurity. France, Germany, Italy, and Spain operate within European animal-health frameworks while adapting controls to national production patterns. The United Kingdom prioritizes surveillance, import safeguards, and farm-level disease prevention. Mexico benefits from integrated vaccination, movement oversight, and practical support for diverse cattle and swine operations. Russia requires attention to extensive geography, regional veterinary capacity, and movement controls.

Leadership Priorities for Prevention, Detection, and Resilience

Industry leaders should establish measurable reproductive-health indicators, including conception performance, abortion investigations, stillbirths, and neonatal survival, and review them routinely with veterinarians. They should maintain written biosecurity plans covering sourcing, quarantine, visitor access, sanitation, breeding materials, carcass handling, and animal movement. Testing should be risk-based and linked to clear response protocols, while vaccination programs should reflect veterinary guidance, local disease status, and product requirements. Investments in interoperable records, laboratory partnerships, staff training, and producer education can improve early warning. Leaders should also evaluate AI tools through transparent validation, human oversight, data-governance controls, and measurable improvements in detection or response.

Methodology for a Verified Executive Assessment

This assessment uses the defined market scope of cattle and porcine or swine reproductive diseases and synthesizes established animal-health principles across prevention, surveillance, diagnosis, treatment stewardship, biosecurity, production systems, and regional operating conditions. Geographic discussion follows the requested regions, groups, and countries. The analysis is qualitative and intentionally excludes market estimates, sizing, shares, forecasts, and company-specific claims. Conclusions should be validated against current national disease notifications, veterinary guidance, laboratory evidence, regulatory requirements, and farm-level records before operational use.

Coordinated Prevention Is the Core Strategic Imperative

Reproductive disease control is most effective when herd records, veterinary expertise, laboratory diagnostics, biosecurity, vaccination, movement management, and producer capability operate as one system. Regional and country differences require flexible implementation, but the underlying priorities are consistent: detect change early, investigate losses systematically, protect breeding populations, use medicines responsibly, and learn from verified data. Organizations that build these capabilities can strengthen animal welfare, operational continuity, and resilience across cattle and swine production.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cattle & Porcine/Swine Reproductive Diseases Market, by Disease Type
7.1. Introduction
7.2. Bovine Viral Diarrhea (BVD)
7.3. Brucellosis
7.4. Campylobacteriosis
7.5. Infectious Bovine Rhinotracheitis (IBR)
7.6. Leptospirosis
7.7. Neosporosis
7.8. Porcine Parvovirus (PPV)
7.9. Porcine Reproductive and Respiratory Syndrome (PRRS)
7.10. Swine Dysentery
7.11. Trichomoniasis
8. Cattle & Porcine/Swine Reproductive Diseases Market, by Animal Type
8.1. Introduction
8.2. Cattle
8.2.1. Beef Cattle
8.2.2. Dairy Cattle
8.3. Swine
8.3.1. Breeding Swine
8.3.2. Finishing Pigs
8.3.3. Nursery Pigs
9. Cattle & Porcine/Swine Reproductive Diseases Market, by Diagnosis Type
9.1. Introduction
9.2. Culturing Techniques
9.2.1. Bacterial Culture
9.2.2. Viral Isolation
9.3. Diagnostic Imaging
9.3.1. Ultrasonography
9.3.2. X-Ray Imaging
9.4. Molecular Methods
9.4.1. LAMP Assays
9.4.2. PCR
9.5. Serological Tests
9.5.1. AGID
9.5.2. ELISA
9.5.3. SNT
10. Cattle & Porcine/Swine Reproductive Diseases Market, by Treatment Type
10.1. Introduction
10.2. Alternative Therapies
10.2.1. Herbal Treatments
10.2.2. Homoeopathy
10.3. Pharmaceuticals
10.3.1. Antibiotics
10.3.2. Antiparasitics
10.3.3. Antivirals
10.4. Surgical Interventions
10.4.1. Corrective Surgeries
10.4.2. Prophylactic Surgeries
10.5. Vaccinations
10.5.1. Inactivated Vaccines
10.5.2. Live Attenuated Vaccines
11. Cattle & Porcine/Swine Reproductive Diseases Market, by End-User
11.1. Introduction
11.2. Farms
11.3. Research Institutions
11.4. Veterinary Clinics
12. Cattle & Porcine/Swine Reproductive Diseases Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Cattle & Porcine/Swine Reproductive Diseases Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Cattle & Porcine/Swine Reproductive Diseases Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Anicon Labor GmbH
16.2. Biogenesis Bago SA
16.3. Biomin Holding GmbH
16.4. Boehringer Ingelheim Animal Health
16.5. CEVA Santé Animale
16.6. Dechra Pharmaceuticals PLC
16.7. Eco Animal Health Group plc
16.8. Elanco Animal Health Incorporated
16.9. Hipra
16.10. Huvepharma EOOD
16.11. Huvepharma Inc.
16.12. IDEXX Laboratories, Inc.
16.13. Innovacyn, Inc.
16.14. Kaneka Corporation (via subsidiary)
16.15. Medovent GmbH
16.16. Merck Animal Health
16.17. MSD Animal Health
16.18. Neogen Corporation
16.19. Norbrook Laboratories Ltd.
16.20. Vetoquinol Global
16.21. Virbac S.A.
16.22. Zoetis Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Cattle & Porcine/Swine Reproductive Diseases Market, Years Considered for the Study
FIGURE 2. Global Cattle & Porcine/Swine Reproductive Diseases Market, Research Design
FIGURE 3. Global Cattle & Porcine/Swine Reproductive Diseases Market, Research Framework
FIGURE 4. Global Cattle & Porcine/Swine Reproductive Diseases Market, Data Triangulation
FIGURE 5. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2025 vs 2032 (%)
FIGURE 7. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 9. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2025 vs 2032 (%)
FIGURE 11. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2025 vs 2032 (%)
FIGURE 13. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 15. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Cattle & Porcine/Swine Reproductive Diseases Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Cattle & Porcine/Swine Reproductive Diseases Market Segmentation & Coverage
TABLE 2. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, 2017-2032 (USD Million)
TABLE 3. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 4. Global Bovine Viral Diarrhea (BVD) Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Bovine Viral Diarrhea (BVD) Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Bovine Viral Diarrhea (BVD) Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Brucellosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Brucellosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Brucellosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Campylobacteriosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Campylobacteriosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Campylobacteriosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Infectious Bovine Rhinotracheitis (IBR) Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Infectious Bovine Rhinotracheitis (IBR) Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Infectious Bovine Rhinotracheitis (IBR) Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Leptospirosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Leptospirosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Leptospirosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Neosporosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Neosporosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Neosporosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Porcine Parvovirus (PPV) Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Porcine Parvovirus (PPV) Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Porcine Parvovirus (PPV) Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Swine Dysentery Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Swine Dysentery Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Swine Dysentery Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Trichomoniasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Trichomoniasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Trichomoniasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 35. Global Cattle Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Cattle Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Cattle Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Beef Cattle Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Beef Cattle Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Beef Cattle Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Dairy Cattle Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Dairy Cattle Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Dairy Cattle Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Swine Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Swine Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Swine Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Breeding Swine Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Breeding Swine Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Breeding Swine Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Finishing Pigs Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Finishing Pigs Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Finishing Pigs Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Nursery Pigs Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Nursery Pigs Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Nursery Pigs Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2017-2032 (USD Million)
TABLE 57. Global Culturing Techniques Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Culturing Techniques Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Culturing Techniques Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Bacterial Culture Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Bacterial Culture Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Bacterial Culture Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Viral Isolation Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Viral Isolation Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Viral Isolation Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Diagnostic Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Diagnostic Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Diagnostic Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Ultrasonography Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Ultrasonography Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Ultrasonography Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global X-Ray Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global X-Ray Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global X-Ray Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Molecular Methods Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Molecular Methods Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Molecular Methods Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global LAMP Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global LAMP Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global LAMP Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Serological Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Serological Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Serological Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global AGID Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global AGID Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global AGID Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global ELISA Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global ELISA Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global ELISA Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global SNT Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global SNT Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global SNT Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 97. Global Alternative Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Alternative Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Alternative Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Herbal Treatments Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Herbal Treatments Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Herbal Treatments Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Homoeopathy Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Homoeopathy Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Homoeopathy Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Pharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Pharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Pharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Antibiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Antiparasitics Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Antiparasitics Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Antiparasitics Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Antivirals Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Antivirals Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Antivirals Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Surgical Interventions Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Surgical Interventions Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Surgical Interventions Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Corrective Surgeries Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Corrective Surgeries Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Corrective Surgeries Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Prophylactic Surgeries Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Prophylactic Surgeries Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Prophylactic Surgeries Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Vaccinations Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Vaccinations Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Vaccinations Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Inactivated Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Inactivated Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Inactivated Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Live Attenuated Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Live Attenuated Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Live Attenuated Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2017-2032 (USD Million)
TABLE 137. Global Farms Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Farms Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Farms Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Cattle, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Swine, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Culturing Techniques, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Molecular Methods, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Serological Tests, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Alternative Therapies, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Surgical Interventions, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by Vaccinations, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2017-2032 (USD Million)
TABLE 163. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 165. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 166. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Cattle, 2017-2032 (USD Million)
TABLE 167. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Swine, 2017-2032 (USD Million)
TABLE 168. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2017-2032 (USD Million)
TABLE 169. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Culturing Techniques, 2017-2032 (USD Million)
TABLE 170. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 171. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Molecular Methods, 2017-2032 (USD Million)
TABLE 172. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Serological Tests, 2017-2032 (USD Million)
TABLE 173. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 174. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Alternative Therapies, 2017-2032 (USD Million)
TABLE 175. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 176. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Surgical Interventions, 2017-2032 (USD Million)
TABLE 177. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Vaccinations, 2017-2032 (USD Million)
TABLE 178. North America Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2017-2032 (USD Million)
TABLE 179. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 181. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 182. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Cattle, 2017-2032 (USD Million)
TABLE 183. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Swine, 2017-2032 (USD Million)
TABLE 184. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2017-2032 (USD Million)
TABLE 185. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Culturing Techniques, 2017-2032 (USD Million)
TABLE 186. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 187. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Molecular Methods, 2017-2032 (USD Million)
TABLE 188. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Serological Tests, 2017-2032 (USD Million)
TABLE 189. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 190. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Alternative Therapies, 2017-2032 (USD Million)
TABLE 191. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 192. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Surgical Interventions, 2017-2032 (USD Million)
TABLE 193. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by Vaccinations, 2017-2032 (USD Million)
TABLE 194. Latin America Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2017-2032 (USD Million)
TABLE 195. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 197. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 198. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Cattle, 2017-2032 (USD Million)
TABLE 199. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Swine, 2017-2032 (USD Million)
TABLE 200. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2017-2032 (USD Million)
TABLE 201. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Culturing Techniques, 2017-2032 (USD Million)
TABLE 202. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 203. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Molecular Methods, 2017-2032 (USD Million)
TABLE 204. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Serological Tests, 2017-2032 (USD Million)
TABLE 205. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 206. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Alternative Therapies, 2017-2032 (USD Million)
TABLE 207. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 208. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Surgical Interventions, 2017-2032 (USD Million)
TABLE 209. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by Vaccinations, 2017-2032 (USD Million)
TABLE 210. Europe Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2017-2032 (USD Million)
TABLE 211. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 212. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 213. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 214. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Cattle, 2017-2032 (USD Million)
TABLE 215. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Swine, 2017-2032 (USD Million)
TABLE 216. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2017-2032 (USD Million)
TABLE 217. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Culturing Techniques, 2017-2032 (USD Million)
TABLE 218. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 219. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Molecular Methods, 2017-2032 (USD Million)
TABLE 220. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Serological Tests, 2017-2032 (USD Million)
TABLE 221. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 222. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Alternative Therapies, 2017-2032 (USD Million)
TABLE 223. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 224. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Surgical Interventions, 2017-2032 (USD Million)
TABLE 225. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by Vaccinations, 2017-2032 (USD Million)
TABLE 226. Middle East Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2017-2032 (USD Million)
TABLE 227. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 228. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 229. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 230. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Cattle, 2017-2032 (USD Million)
TABLE 231. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Swine, 2017-2032 (USD Million)
TABLE 232. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2017-2032 (USD Million)
TABLE 233. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Culturing Techniques, 2017-2032 (USD Million)
TABLE 234. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 235. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Molecular Methods, 2017-2032 (USD Million)
TABLE 236. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Serological Tests, 2017-2032 (USD Million)
TABLE 237. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 238. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Alternative Therapies, 2017-2032 (USD Million)
TABLE 239. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 240. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Surgical Interventions, 2017-2032 (USD Million)
TABLE 241. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by Vaccinations, 2017-2032 (USD Million)
TABLE 242. Africa Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2017-2032 (USD Million)
TABLE 243. Global Cattle & Porcine/Swine Reproductive Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 244. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 245. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 246. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 247. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Cattle, 2017-2032 (USD Million)
TABLE 248. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Swine, 2017-2032 (USD Million)
TABLE 249. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2017-2032 (USD Million)
TABLE 250. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Culturing Techniques, 2017-2032 (USD Million)
TABLE 251. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 252. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Molecular Methods, 2017-2032 (USD Million)
TABLE 253. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Serological Tests, 2017-2032 (USD Million)
TABLE 254. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 255. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Alternative Therapies, 2017-2032 (USD Million)
TABLE 256. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 257. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Surgical Interventions, 2017-2032 (USD Million)
TABLE 258. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by Vaccinations, 2017-2032 (USD Million)
TABLE 259. ASEAN Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2017-2032 (USD Million)
TABLE 260. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 261. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 262. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 263. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Cattle, 2017-2032 (USD Million)
TABLE 264. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Swine, 2017-2032 (USD Million)
TABLE 265. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2017-2032 (USD Million)
TABLE 266. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Culturing Techniques, 2017-2032 (USD Million)
TABLE 267. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 268. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Molecular Methods, 2017-2032 (USD Million)
TABLE 269. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Serological Tests, 2017-2032 (USD Million)
TABLE 270. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 271. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Alternative Therapies, 2017-2032 (USD Million)
TABLE 272. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 273. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Surgical Interventions, 2017-2032 (USD Million)
TABLE 274. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by Vaccinations, 2017-2032 (USD Million)
TABLE 275. GCC Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2017-2032 (USD Million)
TABLE 276. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 277. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 278. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 279. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Cattle, 2017-2032 (USD Million)
TABLE 280. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Swine, 2017-2032 (USD Million)
TABLE 281. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2017-2032 (USD Million)
TABLE 282. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Culturing Techniques, 2017-2032 (USD Million)
TABLE 283. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 284. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Molecular Methods, 2017-2032 (USD Million)
TABLE 285. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Serological Tests, 2017-2032 (USD Million)
TABLE 286. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 287. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Alternative Therapies, 2017-2032 (USD Million)
TABLE 288. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 289. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Surgical Interventions, 2017-2032 (USD Million)
TABLE 290. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by Vaccinations, 2017-2032 (USD Million)
TABLE 291. European Union Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2017-2032 (USD Million)
TABLE 292. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 293. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 294. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 295. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Cattle, 2017-2032 (USD Million)
TABLE 296. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Swine, 2017-2032 (USD Million)
TABLE 297. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2017-2032 (USD Million)
TABLE 298. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Culturing Techniques, 2017-2032 (USD Million)
TABLE 299. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 300. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Molecular Methods, 2017-2032 (USD Million)
TABLE 301. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Serological Tests, 2017-2032 (USD Million)
TABLE 302. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 303. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Alternative Therapies, 2017-2032 (USD Million)
TABLE 304. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 305. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Surgical Interventions, 2017-2032 (USD Million)
TABLE 306. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by Vaccinations, 2017-2032 (USD Million)
TABLE 307. BRICS Cattle & Porcine/Swine Reproductive Diseases Market Size, by End-User, 2017-2032 (USD Million)
TABLE 308. G7 Cattle & Porcine/Swine Reproductive Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 309. G7 Cattle & Porcine/Swine Reproductive Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 310. G7 Cattle & Porcine/Swine Reproductive Diseases Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 311. G7 Cattle & Porcine/Swine Reproductive Diseases Market Size, by Cattle, 2017-2032 (USD Million)
TABLE 312. G7 Cattle & Porcine/Swine Reproductive Diseases Market Size, by Swine, 2017-2032 (USD Million)
TABLE 313. G7 Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnosis Type, 2017-2032 (USD Million)
TABLE 314. G7 Cattle & Porcine/Swine Reproductive Diseases Market Size, by Culturing Techniques, 2017-2032 (USD Million)
TABLE 315. G7 Cattle & Porcine/Swine Reproductive Diseases Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 316. G7 Cattle & Porcine/Swine Reproductive Diseases Market Size, by Molecular Methods, 2017-2032 (USD Million)
TABLE 317. G7 Cattle & Porcine

Companies Mentioned

  • Anicon Labor GmbH
  • Biogenesis Bago SA
  • Biomin Holding GmbH
  • Boehringer Ingelheim Animal Health
  • CEVA Santé Animale
  • Dechra Pharmaceuticals PLC
  • Eco Animal Health Group plc
  • Elanco Animal Health Incorporated
  • Hipra
  • Huvepharma EOOD
  • Huvepharma Inc.
  • IDEXX Laboratories, Inc.
  • Innovacyn, Inc.
  • Kaneka Corporation (via subsidiary)
  • Medovent GmbH
  • Merck Animal Health
  • MSD Animal Health
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Vetoquinol Global
  • Virbac S.A.
  • Zoetis Inc.

Related Topics

Related Reports

Cattle and Porcine/Swine Reproductive Diseases Market Size, Share & Growth Analysis Report - Industry Trends, Competitive Landscape, Segment Insights and Forecast 2024-2034 - Product Image

Cattle and Porcine/Swine Reproductive Diseases Market Size, Share & Growth Analysis Report - Industry Trends, Competitive Landscape, Segment Insights and Forecast 2024-2034

  • Report
  • 160 Pages
  • Global
From
Cattle Breeding Market - Global Forecast 2026-2032 - Product Image

Cattle Breeding Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Cattle Management Software Market - Global Forecast 2026-2032 - Product Image

Cattle Management Software Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Beef Cattle Health Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Beef Cattle Health Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 109 Pages
  • Global
From
Cattle Vaccine Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Cattle Vaccine Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.